SciELO - Scientific Electronic Library Online

 
vol.28 suppl.2Current medical treatment of diabetes type 2 and long term morbidity: how to balance efficacy and safety?Management of patients with type 2 diabetes before and after bariatric surgery: evolution and microvascular complications author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Nutrición Hospitalaria

On-line version ISSN 1699-5198Print version ISSN 0212-1611

Abstract

COHEN, R.. Metabolic surgery: who and when?: Is there a good answer?. Nutr. Hosp. [online]. 2013, vol.28, suppl.2, pp.14-16. ISSN 1699-5198.

Currently there is little doubt that the body mass index (BMI) is not an appropriate tool to grant access to metabolic surgery, especially in type 2 diabetics (T2D). Several studies are pointing towards other parameters that should go along with BMI in the treatment decision tree in non morbidly obese diabetics. Insulin resistance, fat distribution among others are considered good tools to predict favorable outcomes in medically non controlled diabetics if sent to surgery. The bottom line in good T2D control is to decrease cardiovascular mortality. Using adequate tools to screen patients to the appropriate surgical treatment may favor patients that are not under control after lifestyle changes and best medical treatment, thus decreasing longterm cardiovascular mortality secondary to type 2 diabetes.

Keywords : Metabolic surgery; Selection criteria; BMI; Insulin resistance; Fat distribution.

        · abstract in Spanish     · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License